Sitagliptin and tofacitinib ameliorate adjuvant induced arthritis via modulating the cross talk between JAK/STAT and TLR-4/NF-κB signaling pathways
Sherihan Salaheldin Abdelhamid Ibrahim, Mona Abdelrazek Salama, Eman Selima, Rowaida R Shehata
Topics & Concepts
TofacitinibSitagliptinMedicineJanus kinasePharmacologyArthritisSTAT proteinJAK-STAT signaling pathwaySignal transductionInternal medicineRheumatoid arthritisEndocrinologyCancer researchImmunologyCytokineReceptorTyrosine kinaseChemistrySTAT3MetforminDiabetes mellitusBiochemistryRheumatoid Arthritis Research and TherapiesCytokine Signaling Pathways and InteractionsSpondyloarthritis Studies and Treatments